News Focus
News Focus
icon url

The Rainmaker

03/07/11 5:30 PM

#2668 RE: azrider9 #2667

How many shares do you think RPC has O/S, they just issued 128 million new shares to settle debt on top of the 60m shares they already had O/S. I think they have close to 200m shares O/S now versus BMOD under a 100m. RPC had a market cap closer to $80 million dollars when they were halted. Compare that to BMOD's 15m market cap. RPC stock was over $2.00 a couple of months ago. Compare that old market cap RPC had when it was over $2.00 with BMOD's dramatically lower market cap and it is apparent to me BMOD is very undervalued provided they release those PII results.
icon url

The Rainmaker

03/07/11 5:39 PM

#2669 RE: azrider9 #2667

Interestingly, they are also further ahead on several important fronts they'll need to keep this moving forward. They have had an extra four months to prepare the Phase III trial protocols and to line up extra test sites. They have been working with Quinteles on the automation process gearing up for large scale mass use of Cypath. Also, they have started prepping Cypath for testing on other types of cancer. Plus, any University or Government funding deals they might have lined up based off good Phase II results. Everything could happen one right after the other....All triggered by release of PII results later this month.